From time to time, Pharma Marketing Network hosts surveys of subscribers and visitors to the website. These surveys give you an opportunity to offer your opinions and insights on important pharmaceutical marketing issues. After taking the survey, you can view a summary of the de-identified survey results.
Surveys are conducted anonymously, meaning you do not have to supply your name or contact information. However, you may opt in to provide this information so that we may contact you for more details or to quote you in any article we may write summarizing the results of the survey.
Featured Survey
Direct-to-Consumer Off-Label Drug Promotion Survey
This survey solicits your opinion possible FDA future decisions regarding off-label drug promotion to patient and consumer audiences. For more background information, read “FDA May Have No Choice But to Allow Direct-to-Consumer Off-Label Drug Promotion.”
CLICK HERE to take the survey
Other Featured Surveys
Tell Us About Your Social Media Listening Program
Social media listening is a hot topic these days. There is no doubt that collecting information from disease and product conversations on social media sites helps pharmaceutical companies develop more impactful messaging and marketing tactics.
This survey is an attempt to understand how pharmaceutical companies and their agencies are using social media listening programs as a part of their marketing and communications programs.
CLICK HERE to take the survey
Pharma Marketing Buzzwords: Good, Bad, or Just Useless?
There’s a lot of “buzz” about pharma marketing buzzwords these days. Several industry experts suggest that the overuse of many of these buzzwords contributes to the bad reputation of the drug industry by alienating patients and physicians. What do you think?
CLICK HERE to take the survey
All Surveys & Results
Access the results of the following surveys. Some may still be open for participation.
-
- Answers to FDA’s Questions Regarding Pharma’s Use of Social Media
- Appropriate Messaging at Point of Care
- Are FDA’s New Revised “Rules” for Distribution of Off-label Reprints Too Limiting?
- Buzz ‘n Blog Pharma Marketing
- Disease Mongering: Real or Fantasy?
- Direct-to-Consumer Off-Label Drug Promotion Survey
- Distribution of Off-Label Drug Information by Pharmaceutical Companies
- Evidence-based Marketing
- Grading Pharma’s Favorite Buzzwords: the Good, the Bad, the Useless
- Harry’s Drug Risk Parlor Game
- How the Drug Industry Can Earn Back the Public’s Trust
- How Should Pharma Edit Wikipedia Drug Articles?
- Impact of the PhRMA Code on Pharmaceutical Marketing and Sales
- Messaging/Advertising within ePrescribing Applications
- Moderation of Pharma Social Media Discussions
- New Media Privacy Issues & Online Health Marketing
- Pharma Cost Cutting
- Pharma Gifts to Physicians
- Pharma Mobile Health App Best Practices Survey
- Pharma PR vs Advertising
- Pharma Search Engine Marketing
- Pharma-Sponsored Medical Article Ghost Writing
- Pharma Use of Rx Data
- Potential for Bias in Commercially Supported CME
- Predicting the Future of the Drug Industry: 2010 and Beyond
- Profile of Pharmaguy’s Twitter Followers
- Regulation of Pharma-Sponsored CME
- REMS Impact on Pharma Marketing
- Role of Direct-to-Consumer Advertising
- Rules for Pharma Engagement in Patient/Physician Social Networks
- Should FDA Be Reformed?
- Should Free Drug Samples Be Banned?
- Social Media Pharma Marketing Readiness Self-Assessment
- Should Pharma Advertisers Use Redirect URLs in Search Engine Ads?
- Should Pharma Hire Online “Patient Opinion Leaders”?
- Should Pharma’s Use of #MedConf Hashtags Be Curbed?
- Use of Behavioral Targeting by Pharma Marketers
- Use of Patient Testimonials in DTC & Social Media Advertising
- Value of Direct-to-Consumer Advertising
- The Value of Social, Mobile, & Gaming Technologies for Improving Adherence
- What Do You Think of FDA’s Recent Regulatory Actions?
- What’s the Best Way for Pharma to Support CME?
- What’s the Future of Direct-to-Consumer Advertising?
- What’s Your Opinion About Branded Patient Support via Twitter?
- What’s Your Social Media Implementation Plan?
- Which Future US Health Care Scenario is Best for Pharma?
- Who Should Be Pharma’s Social Media Voice? PR or Brand?
